Blenrep is a registered trademark of the GlaxoSmithKline group of companies
▼This medicine is subject to additional monitoring. This will allow quick identification of new safety information. Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GlaxoSmithKline on 0800 221 441.
August 2022 | NP-GB-BLM-WCNT-220002 (V1.0)
August 2022 | NP-GB-BLM-WCNT-220002 v1.0
Get in touch
To report an adverse event or any other general enquiry.